SOD1 and amyotrophic lateral sclerosis: In the clinical trial NCT00706147, rapidly progressive SOD1‐mutant ALS patients were treated with up to 200 mg arimoclomol and this Phase II trial showed that arimoclomol is safe and well‐tolerated.98